Managing the global burden of cardiovascular disease

There is a large and increasing global burden of cardiovascular disease. Approximately 14 million individuals died of cardiovascular disease in 1990, and this is projected to rise to about 25 million by 2020. In large part, this increase can be explained on the basis of major ongoing sociodemographic changes in developing countries, and associated effects on the numbers of individuals at risk and the levels of cardiovascular risk factors. Developing countries now experience a much greater burden of cardiovascular disease than do developed countries. In addition, developing countries are expected to experience the greatest rise in cardiovascular disease burden over the next few years. Cardiovascular disease prevention programmes designed and implemented primarily in developed countries have most likely averted much premature cardiovascular disease in those countries over the past few decades. However, cardiovascular disease prevention programmes designed for developed countries are unlikely to be directly transferable to developing countries. Reliable information to inform the design and implementation of cardiovascular disease prevention programmes, tailored to the socioeconomic circumstances of developing countries, is now required. Such programmes have great potential to impact on the current and projected global epidemic of cardiovascular disease.

[1]  P. Mullen,et al.  A meta-analysis of controlled trials of cardiac patient education. , 1992, Patient education and counseling.

[2]  P. Puska The North Karelia Project: nearly 20 years of successful prevention of CVD in Finland. , 1992, Hygie.

[3]  B Neal,et al.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials , 2000, The Lancet.

[4]  J. Catford,et al.  Effects of the Heartbeat Wales programme over five years on behavioural risks for cardiovascular disease: quasi-experimental comparison of results from Wales and a matched reference area , 1998, BMJ.

[5]  Z. Li,et al.  Blood pressure, cholesterol, and stroke in eastern Asia , 1998, The Lancet.

[6]  B. Jalaludin,et al.  Prevalence of diabetes, hypertension and obesity at different levels of urbanisation in Vanuatu , 1991, The Medical journal of Australia.

[7]  R. Doll,et al.  Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors , 1994, BMJ.

[8]  R. Collins,et al.  Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. , 1994, British medical bulletin.

[9]  A. Drewnowski,et al.  The nutrition transition: new trends in the global diet. , 2009, Nutrition reviews.

[10]  D. Kromhout Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts , 1995, The Lancet.

[11]  R. Hakeem,et al.  Urbanisation and coronary heart disease risk factors in South Asian children. , 2001, JPMA. The Journal of the Pakistan Medical Association.

[12]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[13]  R. Carleton,et al.  The Pawtucket Heart Health Program: community changes in cardiovascular risk factors and projected disease risk. , 1995, American journal of public health.

[14]  Richard Doll,et al.  Mortality in relation to smoking: 22 years' observations on female British doctors. , 1980, British medical journal.

[15]  R. Collins,et al.  Early health effects of the emerging tobacco epidemic in China. A 16-year prospective study. , 1997 .

[16]  A. Folsom,et al.  Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. , 1994, American journal of public health.

[17]  Bruce Neal,et al.  1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. , 1999, Journal of hypertension.

[18]  Alan D. Lopez,et al.  Assessing the burden of mortality from cardiovascular diseases. , 1993, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[19]  H. Vorster,et al.  An epidemiological study of hypertension and its determinants in a population in transition: the THUSA study , 2000, Journal of Human Hypertension.

[20]  J. Tuomilehto,et al.  Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years , 1988 .

[21]  P Barham,et al.  Management of raised blood pressure in New Zealand: a discussion document. , 1993, BMJ.

[22]  C. Yao,et al.  The changing pattern of cardiovascular diseases in China. , 1993, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[23]  W L Haskell,et al.  Effects of communitywide education on cardiovascular disease risk factors. The Stanford Five-City Project. , 1990, JAMA.

[24]  R. Hakeem,et al.  Rural-urban differences in food and nutrient intake of Pakistani children. , 1999, JPMA. The Journal of the Pakistan Medical Association.

[25]  D. Yach,et al.  Globalisation of tobacco industry influence and new global responses , 2000, Tobacco control.

[26]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[27]  L. Beckett,et al.  Serial changes in blood pressure from adolescence into adulthood. , 1992, American journal of epidemiology.

[28]  Charles Kenny,et al.  World development report 1999/2000 : entering the 21st century , 1999 .